Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Women Face Higher Risks of Heartmate II Complications: Study December 19, 2013 Irvin Jackson Add Your Comments A new study suggests that women may be more likely than men to face complications from the Thoratec HeartMate II left ventricular assist system (LVAS), which is a mechanical heart pump that has recently been linked to a potential risk of blood clots and other problems. Â Researchers from the Cleveland Clinic published a retrospective analysis in the Journal of the American College of Cardiology online on December 11, indicating that being female increased the risk of bleeding, stroke and blood clots among patients who received a HeartMate II implant. According to the findings, advanced age, a higher body mass index, and some other health factors appeared to increase the risk of some of the Thoratec HeartMate II complications, but women faced increased risks across the board. Learn More About Thoratec HeartMate II Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Thoratec HeartMate II Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION “The striking finding is that female sex was a risk factor for all four events,” wrote Dr. Samer S. Najjar in an editorial that accompanied the study. “Identifying the additional demographic and clinical factors that modulate the risks of bleeding and thrombosis will enhance our ability to risk-stratify patients with LVADs. The hope is that by integrating this information, the anticoagulation and antiplatelet strategies could be tailored to balance the bleeding and thrombotic profiles of a given patient.” HeartMate II Health Concerns The Thoratec HeartMate II LVAS is a coronary implant given to patients whose hearts are too weak to efficiently pump blood. Former Vice President Dick Cheney is perhaps the most famous recipient, but they have been widely used among individuals with advanced heart disease who are waiting for a heart transplant or are too weak to undergo such a procedure. This study comes less than a month after researchers from the Cleveland Clinic first sounded a warning bell about the potential risk of blood clot problems with the HeartMate II. In a study published last month in the New England Medical Journal researchers indicated that the heart pump may increase the risk of blood clots by a factor of four among patients who had received the device since March 2011.The blood clot complications resulted in the deaths of at least 19 patients since that time. The numbers found a sharp increase in reports of HeartMate II injuries in recent years, even though the device had been on the market for years. Researchers were at a loss as to why blood clot problems with the device suddenly skyrocketed. For HeartMate II pumps implanted before March 2011, the risk of pump thrombosis was at about 2.2% after three months. By January 2013 that rate had increased to 8.4%, leaving some researchers to question whether Thoratec has changed the devices’ design without informing the medical community or the FDA. Thoratec HeartMate II Investigation The FDA has announced it is investigating the findings of that study. A number of product liability lawyers are also reviewing the possibility of whether individuals who experienced problems may be eligible to pursue a claim through a Thoratec HeartMate lawsuit. At least one group representing shareholders is also warning investors about a potential class action against Thoratec, noting that the company’s stocks dropped significantly in value after the HeartMate II concerns came to light. On December 13, Shareholders Foundation noted that at least one law firm was investigating Thoratec Corporation over potential securities laws violations, in connection with financial statements the company had made. The investigation is focusing on whether the company made a series of statements about its business that were materially false and misleading. The Foundation notes that Thoratech shares reached a 2013 high of $43.30 as of November 15 of this year. But following the November 27 announcement by the Cleveland Clinic the shares began dropping, and were down to $35.68 per share by December 13. Tags: Bleeding, Blood Clot, Deep Vein Thrombosis, HeartMate, Investor Lawsuit, Stroke, Thoratec Image Credit: | More HeartMate Lawsuit Stories Medtronic HVAD Stroke Risk May Be Higher Than HeartMate3: Study August 19, 2021 Abbott Warns of New Problems With HeartMate 3 Systems December 12, 2019 Heartmate II LVAS Pocket Control Recall Issued Following Deaths, Malfunctions May 25, 2017 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025) Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025) Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)
Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025)
Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)
Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)